Ye, Ruisong <br/><br/>
CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.  [electronic resource] 

 -  Journal of experimental & clinical cancer research : CR  06 2017 
 - 90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1756-9966 
<br/><br/><label>Standard No.: </label>10.1186/s13046-017-0561-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CRISPR-Cas Systems<br/>Cell Line, Tumor<br/>Cell Movement--genetics<br/>Cell Proliferation<br/>Cell Transformation, Neoplastic--genetics<br/>Disease Models, Animal<br/>Gene Editing<br/>Gene Order<br/>Gene Targeting<br/>Genetic Vectors--genetics<br/>HEK293 Cells<br/>Humans<br/>Ligands<br/>Male<br/>Mice<br/>Prostatic Neoplasms--genetics<br/>Receptors, G-Protein-Coupled--chemistry<br/>Xenograft Model Antitumor Assays